US hits at Huawei innovation with blacklist of R&D centers

Washington expands campaign against China's tech flagship

The crackdown on Huawei's R&D facilities could hinder innovation, analysts say. Clockwise from top right, the Beijing Research Center, the Chengdu Research Center, the Shanghai Research Center and the Hangzhou Research Center.

LAULY LI and CHENG TING-FANG, Nikkei staff writers

August 21, 2019 11:34 JST

TAIPEI -- Washington has blacklisted more than 20% of Huawei Technologies' global R&D and innovation centers in its latest crackdown on the Chinese tech giant, striking at the heart of the company's ability to innovate.

At least 11 of Huawei's key research facilities, including sites in the U.K. and Italy, were named on a new list of 46 affiliates with which U.S. companies cannot trade unless they have Washington's approval.